BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Allay Therapeutics Announces Expansion of Clinical and Scientific Advisory Boards to Support the Company’s Mission to Transform Post-Surgical Pain Management

  October 24, 2024

   · 

  12 min read
• 

  Weight loss

  Viking to Accelerate Development of Obesity Drug With Two Q4 Catalysts

  Following an end-of-Phase II meeting with the FDA in the fourth quarter, Viking Therapeutics plans to push its subcutaneous obesity therapy VK2735 into late-stage development and to start a Phase II trial for an oral formulation.

  October 24, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Diabetes

  GLP-1 Prescriptions for Type 1 Diabetes Spike Despite Lack of FDA Approval: Study

  While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has sharply increased, according to researchers, who warn about the risk of serious side effects such as ketoacidosis.

  October 24, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Vaccines

  CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64

  The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.

  October 24, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Drug Development

  First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer

  October 24, 2024

   · 

  10 min read
• Press Releases

  Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program

  October 24, 2024

   · 

  6 min read
• News

  BioIVT to Highlight New Ki67 Tissue Staining Service at Biomarkers U.S. 2024 and The Society for Immunotherapy of Cancer (SITC) 2024

  October 24, 2024

   · 

  3 min read
• Business

  Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024

  October 24, 2024

   · 

  2 min read
• Press Releases

  Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives

  October 24, 2024

   · 

  8 min read
• News

  Dermavant Presents Data on Achievement of No-to-Minimal Itch and Sleep Improvement in Atopic Dermatitis Patients as Young as Two Years Old at American College of Allergy, Asthma and Immunology Annual Meeting

  October 24, 2024

   · 

  6 min read